Acromegaly: Role of Surgery in the Therapeutic Armamentarium
Open Access
- 12 November 2012
- journal article
- review article
- Published by Hindawi Limited in International Journal of Endocrinology
- Vol. 2012, 1-13
Abstract
Acromegaly is a complex disease that requires the intervention of a multidisciplinary team. The most frequent clinical manifestations are growing of distal parts of the body and some areas of the face. Patients may also present arterial hypertension, diabetes mellitus, colonic polyps, cardiomegaly, neurological and endocrine changes secondary to the presence of a GH-secreting tumor in pituitary or extrapituitary origin, or eutopic hypothalamic GHRH hypersecretion and peripheral GHRH hypersecretion. Surgery is the first treatment used for most patients, regardless of the cause. In the great majority of cases, pituitary tumor can be removed through a transsphenoidal approach. Craniotomy is reserved for those cases with giant tumors, particularly when they grow toward the middle or posterior cranial fossa. Best surgical results are obtained when the tumor is confined into the sella turcica or if it has a regular suprasellar extension. When the disease cannot be controlled with surgery, medical treatment is indicated. Somatostatin analogues are included as the first line of medication, followed by dopamine agonist and growth hormone receptors antagonists. Radiation therapy can be also indicated in two main forms for residual tumor with medically refractory patients: radiosurgery for small tumors or fractionated stereotactic radiotherapy for larger ones.Keywords
This publication has 40 references indexed in Scilit:
- Somatostatin analogs as a first-line treatment in acromegalyCurrent Opinion in Endocrinology, Diabetes and Obesity, 2012
- Medical Therapy of AcromegalyInternational Journal of Endocrinology, 2012
- Radiation techniques for acromegalyRadiation Oncology, 2011
- Diaphragma Sellae: A Surgical Reference for Transsphenoidal Resection of Pituitary MacroadenomasWorld Neurosurgery, 2011
- Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT)Radiation Oncology, 2011
- Acromegaly without Imaging Evidence of Pituitary AdenomaThe Journal of Clinical Endocrinology & Metabolism, 2010
- Acromegaly pathogenesis and treatmentJournal of Clinical Investigation, 2009
- Management of acromegaly in Latin America: expert panel recommendationsPituitary, 2009
- Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patientsJournal of Neurosurgery, 1988
- Transsphenoidal microsurgery of pituitary macroadenomas with long-term follow-up resultsJournal of Neurosurgery, 1983